Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Pharmacokinetic rationale for the rivastigmine patch.

Cummings J, Lefèvre G, Small G, Appel-Dingemanse S.

Neurology. 2007 Jul 24;69(4 Suppl 1):S10-3. Review.

PMID:
17646618
[PubMed - indexed for MEDLINE]
2.

Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.

Kurz A, Farlow M, Lefèvre G.

Int J Clin Pract. 2009 May;63(5):799-805. doi: 10.1111/j.1742-1241.2009.02052.x. Review.

PMID:
19392927
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease.

Winblad B, Machado JC.

Expert Opin Drug Deliv. 2008 Dec;5(12):1377-86. doi: 10.1517/17425240802542690 . Review.

PMID:
19040398
[PubMed - indexed for MEDLINE]
4.

Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.

Darreh-Shori T, Jelic V.

Expert Opin Drug Saf. 2010 Jan;9(1):167-76. doi: 10.1517/14740330903439717. Review.

PMID:
20021294
[PubMed - indexed for MEDLINE]
5.

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.

Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T.

CNS Neurosci Ther. 2010 Aug;16(4):246-53. doi: 10.1111/j.1755-5949.2010.00141.x. Epub 2010 Apr 16. Review.

PMID:
20370805
[PubMed - indexed for MEDLINE]
6.

Rivastigmine transdermal patch: role in the management of Alzheimer's disease.

Guay DR.

Consult Pharm. 2008 Aug;23(8):598-609. Review.

PMID:
19032006
[PubMed - indexed for MEDLINE]
7.

Rivastigmine in Parkinson's disease dementia.

Lalli S, Albanese A.

Expert Rev Neurother. 2008 Aug;8(8):1181-8. doi: 10.1586/14737175.8.8.1181. Review.

PMID:
18671661
[PubMed - indexed for MEDLINE]
8.

Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.

Sadowsky C, Perez JA, Bouchard RW, Goodman I, Tekin S.

CNS Neurosci Ther. 2010 Spring;16(1):51-60. doi: 10.1111/j.1755-5949.2009.00119.x. Review.

PMID:
20070789
[PubMed - indexed for MEDLINE]
9.

A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.

Cummings J, Winblad B.

Expert Rev Neurother. 2007 Nov;7(11):1457-63. Review.

PMID:
17997695
[PubMed - indexed for MEDLINE]
10.

Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.

Greenspoon J, Herrmann N, Adam DN.

CNS Drugs. 2011 Jul;25(7):575-83. doi: 10.2165/11592230-000000000-00000. Review.

PMID:
21623641
[PubMed - indexed for MEDLINE]
11.

Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.

Dhillon S.

Drugs. 2011 Jun 18;71(9):1209-31. doi: 10.2165/11206380-000000000-00000. Review.

PMID:
21711064
[PubMed - indexed for MEDLINE]
12.

Rationale for transdermal drug administration in Alzheimer disease.

Oertel W, Ross JS, Eggert K, Adler G.

Neurology. 2007 Jul 24;69(4 Suppl 1):S4-9. Review.

PMID:
17646621
[PubMed - indexed for MEDLINE]
13.

Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type.

Dhillon S.

Drugs Aging. 2011 Nov 1;28(11):927-30. doi: 10.2165/11207090-000000000-00000. Review.

PMID:
22054233
[PubMed - indexed for MEDLINE]
14.

A review of rivastigmine: a reversible cholinesterase inhibitor.

Williams BR, Nazarians A, Gill MA.

Clin Ther. 2003 Jun;25(6):1634-53. Review.

PMID:
12860489
[PubMed - indexed for MEDLINE]
15.

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

Polinsky RJ.

Clin Ther. 1998 Jul-Aug;20(4):634-47. Review.

PMID:
9737824
[PubMed - indexed for MEDLINE]
16.

Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease.

Grossberg GT, Sadowsky C, Olin JT.

Int J Clin Pract. 2010 Apr;64(5):651-60. doi: 10.1111/j.1742-1241.2009.02330.x. Epub 2010 Jan 19. Review.

PMID:
20102418
[PubMed - indexed for MEDLINE]
17.

Rivastigmine transdermal patch: in the treatment of dementia of the Alzheimer's type.

Yang LP, Keating GM.

CNS Drugs. 2007;21(11):957-65. Review. No abstract available.

PMID:
17927299
[PubMed - indexed for MEDLINE]
18.

Update on rivastigmine.

Farlow MR.

Neurologist. 2003 Sep;9(5):230-4. Review.

PMID:
14587496
[PubMed - indexed for MEDLINE]
19.

Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings.

Grossberg GT.

Drugs Aging. 2008;25(7):573-84. Review.

PMID:
18582146
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk